Chromocell Therapeutics (Chromocell Therapeutics) Interest Expense : $-1.09 Mil (TTM As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Chromocell Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Chromocell Therapeutics's interest expense for the three months ended in Mar. 2024 was $ -0.63 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.09 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Chromocell Therapeutics's Operating Income for the three months ended in Mar. 2024 was $ -1.93 Mil. Chromocell Therapeutics's Interest Expense for the three months ended in Mar. 2024 was $ -0.63 Mil. Chromocell Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Chromocell Therapeutics Interest Expense Historical Data

The historical data trend for Chromocell Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chromocell Therapeutics Interest Expense Chart

Chromocell Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Interest Expense

-0.14

-0.52

Chromocell Therapeutics Quarterly Data
	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial							-0.05	-0.18	-0.13	-0.16	-0.63

Chromocell Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.09 Mil.

Chromocell Therapeutics (AMEX:CHRO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Chromocell Therapeutics's Interest Expense for the three months ended in Mar. 2024 was $-0.63 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-1.93 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $0.00 Mil.

Chromocell Therapeutics's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Chromocell Therapeutics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Chromocell Therapeutics (Chromocell Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chromocell Therapeutics Corp (AMEX:CHRO) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Chromocell Therapeutics Corp is a clinical-stage biotech company focused on developing and commercializing new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as "NaV1.7", as well as other receptors in the NaV family. NaV1.7 has been genetically validated as a pain receptor in human physiology.